Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
8 February 2019
Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) a
